BioSpace News Archive

Porphyria Market Report on Rising Demand, Future Scope and Regional Forecast by 2030

Forecast to 2030,’ thoroughly examines the Porphyria industry to provide essential data & information for the targeted readers.

July 29, 2022
·
5 min read
Peanut Allergy Market Boosting The Growth with Revolutionary Trends by 2030

Forecast to 2030,’ thoroughly examines the Peanut Allergy industry to provide essential data & information for the targeted readers.

July 29, 2022
·
5 min read
Intermittent Claudication Market Current Perspective with Analysis of Leading Players Report By 2030

Forecast to 2030,’ thoroughly examines the Intermittent Claudication industry to provide essential data & information for the targeted readers.

July 29, 2022
·
5 min read
Hyperhidrosis Market Revolutionary Trends in Industry Growth Statistics By 2030

Forecast to 2030,’ thoroughly examines the Hyperhidrosis industry to provide essential data & information for the targeted readers.

July 29, 2022
·
5 min read
Hematuria Treatment Market – Detailed Analysis of Potential Growth, Emerging Trends and Forecasts Report till 2030

Forecast to 2030,’ thoroughly examines the Hematuria Treatment industry to provide essential data & information for the targeted readers.

July 29, 2022
·
5 min read
Bronchiectasis Treatment Market Research Predicted to Show Substantial Growth in Future by 2030

Forecast to 2030,’ thoroughly examines the Bronchiectasis Treatment industry to provide essential data & information for the targeted readers.

July 29, 2022
·
5 min read
Angioedema Market Growth and Key Business Strategies By Leading Industry Players By 2030

Forecast to 2030,’ thoroughly examines the Angioedema industry to provide essential data & information for the targeted readers.

July 29, 2022
·
6 min read
Pharm Country

Dr. Reddy’s Laboratories enters into a licensing agreement with Slayback Pharma to obtain exclusive rights in the first-to-file ANDA for the private label version of Lumify® in the U.S.

Dr. Reddy’s Laboratories Ltd. today announced that it has entered into a licensing agreement with Princeton, New Jersey based Slayback Pharma LLC (“Slayback”), to acquire rights in Slayback’s Brimonidine Tartrate Ophthalmic Solution 0.025%, the private label equivalent of Lumify® in U.S. Lumify® is an over-the-counter (OTC) eyedrop that can be used to relieve redness of the eye due to minor eye irritations.

July 29, 2022
·
4 min read
Genetown

T2 Biosystems Reports Granting of Inducement Awards - July 29, 2022

T2 Biosystems, Inc. a leader in the rapid detection of sepsis-causing pathogens, announced that it issued inducement awards to twelve new employees.

July 29, 2022
·
1 min read
Policy

FDA Provides Update on Agency Response to Monkeypox Outbreak

, the U.S. Food and Drug Administration is providing an update on its multipronged response to monkeypox in the United States, including its efforts in the areas of diagnostics, vaccines and therapeutics.

July 29, 2022
·
5 min read